Download 04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment... Partnering Opportunities

Brochure
More information from http://www.researchandmarkets.com/reports/2191168/
04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment &
Partnering Opportunities
Description:
This report includes details on 37 emerging medical technology companies that have been identified by LSI's
in-house research team in April 2012.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on most of the companies.
Executive summaries typically include:
- Company Contact Information
- Company Overview (structure, size, year founded, etc.)
- Competitive Landscape
- Technological Advantage
- Stage of Development
- Target Markets
- Financial Summary and Sales Forecasts
- Financing & Partnering Needs
- IP Position & Status
- Management Team
- Exit Strategy
- More
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies
Contents:
BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED
- Sophisticated implants and surgical tools featuring a biomechanically-compliant nail for the fixation of hip
fracture in third age patients suffering from osteoporosis
- Novel allogeneic cell graft with copper chelator technology for use in bone marrow transplants to treat
leukemia and lymphoma in patients without an available familial donor
- Innovative imaging that provides real time and wide field visualization of cancer margins during surgery to
increase tissue conservation and comprehensive removal of cancerous areas, specifically for the treatment
of breast cancer
- Novel screening technology based on oncoproteins to differentiate benign infection from true disease and
detect cervical cancer and other cancers associated with human papillomavirus (HPV)
- Innovative products designed to alleviate pain and enhance physical comfort in those affected by illness,
disability, injury, pressure and poor ergonomics
- Novel portable diagnostic tool to detect a wide variety of protein analytes and un-amplified DNA at point of
care
- Bioprosthetic two-piece tissue valve system for minimally invasive valve replacement utilizing a transapical
approach
- Selective small molecule histone deacetylase inhibitors to treat multiple myeloma with possible indications
for inflammatory, neurodegenerative, infectious and genetic disease
- Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance
wound healing, specifically diabetic macular edema and inflammatory bowel disease
- Novel therapeutics to remove acetaldehyde and other toxic aldehydes that impair protein function and
cause mutation in DNA
- Novel front-line therapies for the treatment of inflammatory bowel disease, specifically ulcerative colitis
- Comprehensive portable device to provide point-of-care diagnostics for a variety of diseases
- Orthobiologic implant to fill bone voids utilizing parathyroid hormone peptides to prevent further bone
loss in osteoporosis and spinal injuries
- Novel non-invasive test to asses infertility and egg quality in women through the use of genetic biomarkers
- Novel therapy to treat iron overload caused by chronic transfusion therapy
- Molecular test to detect pathogens and bacteria that can lead to nosocomial infections
- Invasive fractional flow reserve device analyzer that uses computed tomography images to determine
arterial blood flow and pressure, allowing better diagnosis of ischemic stenosis
- In vivo positron emission tomography imaging agents to detect cancer and autoimmune disease
- Blood-based molecular diagnostics that track multiple biomarkers for early diagnosis of a variety of
diseases including cancer and Alzheimer's
- Innovative aortic valvuloplasty balloon for the treatment of calcific aortic stenosis
- Novel therapeutics to treat diseases affecting mucosal tissue
- Novel monoclonal antibody therapies targeting receptor tyrosine kinases to treat cancers
- Novel cervical collar used in emergency situations to immobilize the neck while chemically cooling to lower
brain temperature to slow metabolism, improve cell membrane stability and reduce inflammation
- Small molecule therapeutics to treat cardiometabolic diseases including
dyslipidemia/hypercholesterolemia and diabetes
- Diagnostic test for lung cancer using biological olfactory sensor arrays
- First-in-class subunit-selective NMDA receptor modulators to treat neuropsychiatric diseases, specifically
schizophrenia and Alzheimer's
- G protein-coupled receptor therapeutics to combat multiple sclerosis
- Small molecule therapeutics for acute central nervous system disorders; the company's lead product is
intended to reduce brain swelling and hemorrhage resulting from ischemic and traumatic injury
- First-in-class oral therapeutic to disrupt the natural course of lactose intolerance by stimulating lactosemetabolizing bacteria in the colon and offering long-term symptom relief
- Aneurysm embolization system that promote rapid, peri-procedural stasis in wide neck ruptured and
unruptured aneurysms, taking the place of traditional coils
- Innovative medical isotopes and cancer treatment elements used in thyroid and respiratory cancer
therapies
- Oral active molecule therapeutic to improve memory and learning in patients with Alzheimer's Disease
- Peptide-based immunotherapy intended to treat and prevent pancreatic cancer by targeting mutated ras
genes
- Oral therapeutics that inhibit the breakdown of calcitonin for the treatment and prevention of osteoporosis
and related bone disease
- Novel anti-angiogenic cancer therapy that inhibits blood supply to prevent tumor growth
- Magnetically targeted drug delivery system enabling patient specific delivery options to treat peripheral
artery disease
- Point-of-care molecular diagnostic device utilizing electrochemicals to provide rapid, enzyme-free detection
of nucleic acids for infectious disease
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2191168/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment &
Partnering Opportunities
Web Address:
http://www.researchandmarkets.com/reports/2191168/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 395
Electronic (PDF) Enterprisewide:
USD 1975
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World